Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-09

Clinical Trial Update: Therapeutic Equivalence Study of Generic Brinzolamide vs Azopt [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 trial comparing generic brinzolamide to Azopt for glaucoma-related indications has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azopt (brinzolamide)
  • brinzolamide (generic) (brinzolamide)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Glaucoma, Open Angle or Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-06-09